Clinical Trial Update: Electroporation Potentiated Immunotherapy in Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating electroporation-potentiated immunotherapy in metastatic pancreatic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: Ole Thorlacius-Ussing, MD, DMSc, Professor of Surgery | Conditions: Pancreas Cancer, Metastatic | Phase 2 | Status: UNKNOWN